The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatologists Concerned High Healthcare Costs May Encourage Patients to Forgo, Delay Treatment

Rheumatologists Concerned High Healthcare Costs May Encourage Patients to Forgo, Delay Treatment

June 14, 2017 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Cognitive/behavioral, physical and occupational therapy are very effective for patients with chronic pain conditions, such as fibromyalgia, says Afton Hassett, PsyD, associate research scientist at the University of Michigan Medical School.

You Might Also Like
  • High Cost of DMARDs Could Limit Medicare Patients’ Treatment Adherence
  • FDA’s Gottlieb Blames Industry ‘Kabuki Drug Pricing’ for High Costs
  • Rising Costs of Biologics in the U.S. Suggest Need for Negotiation Ability
Explore This Issue
June 2017
Also By This Author
  • Should Patients with Rheumatic Disease Switch from Biologic to Biosimilar?

‘There is not much transparency in what the costs really are, or what the drugs even cost to produce, & that is another part of the issue.’ —Dr. O’Dell

“For behavioral therapy, some insurance plans may allow only a few visits a month. Effective behavioral therapy takes time, but many patients can have a good response, and they can learn skills that will benefit them in the long term,” says Dr. Hassett. “Those skills and their benefits do not go away as they do when someone stops taking a drug. They may learn skills to help them sleep better or how to do daily activities in ways that are safer and less likely to aggravate their pain,” she says.

If patients skip therapy sessions because of high out-of-pocket costs, “we all end up paying more in the long run with hospital costs or someone being out of work due to pain,” says Dr. Hassett. “I think insurance companies are running around chasing the illness or the problem instead of focusing on preventive strategies that can be highly effective.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Some of Dr. Poddar’s patients must travel six hours to his Bismarck clinic for an appointment and incur costs like fuel, an overnight motel stay, or time off work in addition to their medications, he says.

“Our patients need the best management at the earliest point in their disease that we can provide it. With the right care for our patients, we can control the morbidities that can happen,” Dr. Poddar says. “Ultimately, the cost of delayed treatment is their quality of life. They can’t get that back. Some of our diseases can cause blindness if patients are not treated. You can’t get your eyesight back.”


Susan Bernstein is a freelance medical journalist based in Atlanta.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

In Brief

Rheumatologists say many of their patients struggle to afford everything from generic drugs to insurance copayments for physical therapy. Our patients need the best management at the earliest point in their disease that we can provide it. With the right care for our patients, we can control the morbidities that can happen. Ultimately, the cost of delayed treatment is their quality of life.

References

  1. Centers for Medicare & Medicaid Services. National Health Expenditure Data Fact Sheet. 2017 Mar.
  2. Henry J. Kaiser Family Foundation. 2016 Employer Health Benefits Survey. 2016 Sep 14.
ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Practice Management Tagged With: Biologics, biosimilar, Compliance, cost, drug, generic, Healthcare, Medication, patient care, Rheumatic Disease, rheumatologist, TreatmentIssue: June 2017

You Might Also Like:
  • High Cost of DMARDs Could Limit Medicare Patients’ Treatment Adherence
  • FDA’s Gottlieb Blames Industry ‘Kabuki Drug Pricing’ for High Costs
  • Rising Costs of Biologics in the U.S. Suggest Need for Negotiation Ability
  • 8 Ways to Help Your Patients with Medication Costs

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.